Podcast
April 29, 2019
Showing 181 - 190 of 2842 results
Resolutions
C24 - Education and Training on the Evidence-Based Diagnosis and Clinical Care of Opioid Use Disorder in Skilled Nursing Facilities
JAMDA
April 18, 2017
Antipsychotics and the Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis of Observational Studies
Studies investigating the association between antipsychotic use and the risk of cerebrovascular accident (CVA) showed inconsistent results.
JAMDA
February 26, 2019
Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study
To assess all-cause mortality patients with dementia treated with typical and atypical antipsychotic drugs (APDs).
JAMDA
December 15, 2014
A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)
Neuropsychiatric symptoms in Alzheimer disease (AD) cause significant distress and present a complex clinical challenge for treatment. Pharmacological treatment options are limited to antipsychotics, which carry extensive safety issues. There is emerging evidence to support the potential benefits of memant...
JAMDA
July 31, 2015
Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis
To establish the mortality risk and adverse events associated with the use of atypical antipsychotic medications in people with Parkinson disease psychosis (PDP) in a clinically defined trial cohort.
JAMDA
February 22, 2022
Patient Perspectives on Substance Use Disorders (SUD) and Opioid Use Disorders (OUD) in the Nursing Home
JAMDA
February 26, 2019